CTKB 8-K 2026-09-29

Cytek Biosciences, Inc. (CTKB) 8-K dated 2026-09-29 — accession 0001193125-26-407330. This URL is the filing, not the CTKB hub.

Cytek Biosciences, Inc. (CTKB) is a medical devices company listed on US.

Cytek Biosciences, Inc. filed a 8-K on 2026-09-29. Accession 0001193125-26-407330.

Cached items: 5.03, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported CTKB revenue for 2025-12-31 was $201.5M. Net income was -$66.5M. Revenue was up 0.5% from 2024-12-31 to 2025-12-31. CTKB currently screens at market cap $421.8M.

Not investment advice. The CTKB SEC hub lists recent forms. The stock page is the research view.